EDGAR Filing Documents for 0001213900-23-051355

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001213900-23-051355

Filing Date

2023-06-23

Accepted

2023-06-23 16:06:17

Documents

Period of Report

2023-06-23

Document Format Files

Seq	Description	Document	Type	Size
1	REPORT OF FOREIGN PRIVATE ISSUER	ea180854-6k_neurosense.htm	6-K	23756
2	PLACEMENT AGENT AGREEMENT, DATED AS OF JUNE 22, 2023, BY AND BETWEEN NEUROSENSE	ea180854ex1-1_neurosense.htm	EX-1.1	44549
3	FORM OF ORDINARY WARRANT	ea180854ex4-1_neurosense.htm	EX-4.1	92588
4	FORM OF PRE-FUNDED WARRANT	ea180854ex4-2_neurosense.htm	EX-4.2	87886
5	OPINION OF GOLDFARB GROSS SELIGMAN & CO	ea180854ex5-1_neurosense.htm	EX-5.1	9700
6	OPINION OF COVINGTON & BURLING LLP	ea180854ex5-2_neurosense.htm	EX-5.2	12370
7	FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF JUNE 22, 2023, BY AND BETWEEN	ea180854ex10-1_neurosense.htm	EX-10.1	224121
8	PRESS RELEASE, DATED JUNE 22, 2023	ea180854ex99-1_neurosense.htm	EX-99.1	11909
9	GRAPHIC	ex5-1_001.jpg	GRAPHIC	11088
10	GRAPHIC	ex5-1_002.jpg	GRAPHIC	36120
11	GRAPHIC	ex5-1_003.jpg	GRAPHIC	13785
12	GRAPHIC	ex5-2_001.jpg	GRAPHIC	3437
13	GRAPHIC	ex99-1_001.jpg	GRAPHIC	7133
	Complete submission text file	0001213900-23-051355.txt		607164

Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562

Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142

NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)